Persistent Activation of Innate Immunity in Patients with Primary Antibody Deficiencies

Figure 4

The intensity of expression of CD64 and CD10 on PMN (a, c, e) and CD14 and CD16 on monocytes (b, d, f), in a CVID patient in different clinical conditions. (a, b) At diagnosis. (c, d) Three months later during an upper respiratory infection with rash. (e, f) Rest state five months after the recovery of infection.